NORDMANN RONALD M
Insider CIK 1189790 · PRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 5,000 | $23.62 | $118.1K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 5,000 | $16.38 | $81.9K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 5,000 | $7.86 | $39.3K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 10,000 | $1.25 | $12.5K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 10,000 | $18.30 | $183.0K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 30,090 | $50.00 | $1.50M | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 1,980 | $50.00 | $99.0K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer | 2012-09-28 | 2012-10-02 | 4,000 | $50.00 | $200.0K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | A Award deriv | 2012-07-02 | 2012-07-05 | 651 | $36.50 | $23.8K | 1,980 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | A Award deriv | 2012-04-02 | 2012-04-04 | 597 | $39.80 | $23.8K | 1,329 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | M Exercise deriv | 2012-03-19 | 2012-03-21 | 7,500 | — | $0 | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 100 | $37.09 | $3.7K | 4,000 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 136 | $37.08 | $5.0K | 4,100 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 300 | $37.07 | $11.1K | 4,236 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 304 | $37.06 | $11.3K | 4,536 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 1,203 | $37.05 | $44.6K | 4,840 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 1,803 | $37.04 | $66.8K | 6,043 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 207 | $37.03 | $7.7K | 7,846 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 507 | $37.02 | $18.8K | 8,053 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 2,940 | $37.01 | $108.8K | 8,560 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | M Exercise | 2012-03-19 | 2012-03-21 | 7,500 | $28.79 | $215.9K | 11,500 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | A Award deriv | 2012-01-05 | 2012-01-09 | 3,816 | — | $0 | 30,090 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | A Award deriv | 2012-01-03 | 2012-01-04 | 732 | $32.45 | $23.8K | 732 | SEC↗ |